Drug Shortage Report for ZOLEDRONIC ACID FOR INJECTION

Last updated on 2022-12-24 History
Report ID 145708
Drug Identification Number 02444739
Brand name ZOLEDRONIC ACID FOR INJECTION
Common or Proper name Zoledronic Acid
Company Name JUNO PHARMACEUTICALS CORP.
Market Status DORMANT
Active Ingredient(s) ZOLEDRONIC ACID
Strength(s) 4MG
Dosage form(s) SOLUTION
Route of administration INTRAVENOUS INTRAVENOUS
Packaging size 5mL Vial
ATC code M05BA
ATC description DRUGS AFFECTING BONE STRUCTURE AND MINERALIZATION
Reason for shortage Disruption of the manufacture of the drug.
Anticipated start date
Actual start date 2021-09-15
Estimated end date 2022-12-23
Actual end date 2022-12-23
Shortage status Resolved
Updated date 2022-12-24
Company comments Discontinuation report initiated
Health Canada comments
Tier 3 Status No
Contact Address 2233 ARGENTIA ROAD
MISSISSAUGA, ONTARIO
CANADA L5N 2X7
Company contact information

Version History

Click on "Compare" below to view the full report history and compare to other versions.

Version Number Date Updated Language
v20 2022-12-24 English Compare
v19 2022-12-23 French Compare
v18 2022-12-23 English Compare
v17 2022-12-23 French Compare
v16 2022-12-23 English Compare
v15 2022-12-23 French Compare
v14 2022-12-23 English Compare
v13 2022-09-22 French Compare
v12 2022-09-22 English Compare
v11 2022-09-22 French Compare
v10 2022-09-22 English Compare
v9 2021-12-08 French Compare
v8 2021-12-08 English Compare
v7 2021-12-08 English Compare
v6 2021-09-16 English Compare
v5 2021-09-15 French Compare
v4 2021-09-15 English Compare
v3 2021-09-15 French Compare
v2 2021-09-15 English Compare
v1 2021-09-15 English Compare

Showing 1 to 20 of 20